(Q40155980)

18 September 2017

1 reference

title

The mechanism of action, pharmacokinetics and toxicity of acyclovir--a review (English)

1 reference

18 September 2017

The mechanism of action, pharmacokinetics and toxicity of acyclovir — A review (English)

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94041-0

5 October 2023

author name string

D. Brigden

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6350472

5 October 2023

P. Whiteman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6350472

5 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6350472

5 October 2023

publication date

1 May 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:S0163445383940410?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94041-0

https://api.elsevier.com/content/article/PII:S0163445383940410?httpAccept=text/plain

5 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94041-0

5 October 2023

1 reference

18 September 2017

volume

6

1 reference

18 September 2017

issue

1 Suppl

1 reference

18 September 2017

page(s)

3-9

1 reference

Treatment of experimental herpes simplex keratitis with acycloguanosine

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

In vitro susceptibility of varicella-zoster virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Influence of Cell Culture Conditions on the Inhibition of Herpes Simplex Virus Type 1 Replication by Acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Preclinical toxicology profile of acyclovir: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Acyclovir kinetics after intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Overview of acyclovir pharmacokinetic disposition in adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Neonatal acyclovir pharmacokinetics in patients with herpes virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Effect of renal failure on the pharmacokinetics of acyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Disposition of intravenous radioactive acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Acyclovir tolerance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Renal function after acyclovir intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Acyclovir therapy for acute herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994041-0

7 January 2021

Acyclovir inhibition of Epstein-Barr virus replication

series ordinal

12

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94041-0

5 October 2023

Identifiers

1 reference

18 September 2017

1 reference